Navigation Links
NBTY to Web Cast Presentation at Canaccord Adams Global Growth Conference; Announces Preliminary Unaudited Net Sales Results for July 2009
Date:8/10/2009

RONKONKOMA, N.Y., Aug. 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it will web cast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the Canaccord Adams Global Growth Conference in Boston on Thursday, August 13, 2009.

The presentation is scheduled to be web cast live on the Company Web site, www.nbty.com, on Thursday, August 13 at 1:00PM Eastern Time.

NBTY's preliminary unaudited net sales results for July 2009 by segment are as follows:

                                         NET SALES
                                (Preliminary and Unaudited)
                                  FOR THE MONTH OF JULY
                                       ($In Millions)

                                                2009        2008    % Change

    Wholesale / US Nutrition                    $125        $105         19%

    North American Retail                        $17         $17         -2%

    European Retail                              $55         $47         17%

    Direct Response / E-Commerce                 $19         $19          1%
                                              -------------------------------
    Total                                       $215        $188         15%
                                              ===============================

Leiner Health Products, which was acquired on July 14, 2008, has been fully integrated into Wholesale / US Nutrition net sales. North American Retail same store sales decreased 3% for the one month period. European Retail net sales for July 2009 include $9 million from Julian Graves, which NBTY acquired on September 16, 2008. Without Julian Graves sales, European Retail net sales decreased 3%. In local currency (British Pound Sterling), excluding Julian Graves sales, European Retail net sales increased 19%.

ABOUT NBTY

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (www.NaturesBounty.com), Vitamin World(R) (www.VitaminWorld.com), Puritan's Pride(R) (www.Puritan.com), Holland & Barrett(R) (www.HollandAndBarrett.com), Rexall(R) (www.Rexall.com), Sundown(R) (www.SundownNutrition.com), MET-Rx(R) (www.MetRX.com), Worldwide Sport Nutrition(R) (www.SportNutrition.com), American Health(R) (www.AmericanHealthUS.com), GNC (UK)(R) (www.GNC.co.uk), DeTuinen(R) (www.DeTuinen.nl), LeNaturiste(TM) (www.LeNaturiste.com), SISU(R) (www.SISU.com), Solgar(R) (www.Solgar.com), Good 'n' Natural(R) (www.goodnnatural.com), Home Health(TM) (www.homehealthus.com), Julian Graves, and Ester-C(R) (www.Ester-C.com) brands. NBTY routinely posts information that may be important to investors on its web site.

        Contact:  Harvey Kamil                            Carl Hymans
                  NBTY, Inc.                              G.S. Schwartz & Co.
                  President & Chief Financial Officer     212-725-4500
                  631-200-2020                            carlh@schwartz.com


'/>"/>
SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
2. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
3. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
4. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
5. Haemonetics Webcast Presentation
6. Presentation at Bio Contact Quebec 2007
7. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
8. Accuray to Webcast Senior Management Presentations at Analyst Day Event
9. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
10. Exelixis Announces October 10 Webcast of Presentation at the 2007 Bio InvestorForum Conference
11. HMS Holdings Corp. Hosts Third Quarter 2007 Financial Teleconference and Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Houston, TX (PRWEB) , ... February 24, 2017 ... ... now offering promotions on tooth replacement options at his office, Antoine Dental Center. ... dental implants for $18,499. Some restrictions may apply, but patients can learn more ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants implicated ... to eight genes that may explain why susceptibility to one of the disorders could ... study published today in the journal npj Schizophrenia. , “There is a wealth ...
(Date:2/24/2017)... New York, NY (PRWEB) , ... February 24, 2017 , ... ... urges: “Security needs to be a top priority because it’s not if you will ... in online safety, especially when it comes to digital health care. , Improvements in ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... concerning this present generation. Yisrayl makes an astounding statement when he says that ... explains that the Bible details the current times so plainly that anyone should be ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis and ... global Urinary Incontinence market. The research answers the following questions: ... for Urinary Incontinence and their clinical attributes? How are they positioned ...
(Date:2/23/2017)... MINNEAPOLIS , Feb. 23, 2017  Cogentix Medical, ... manufactures and markets innovative proprietary products for the urology ... and fiscal year ended December 31, 2016 before the ... The Company will host a conference call and ... on Thursday, March 9, 2017 at 11:00 a.m. Eastern ...
Breaking Medicine Technology: